These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 9436973

  • 1. The usefulness of the reticulin stain in the differential diagnosis of liver nodules on fine-needle aspiration biopsy cell block preparations.
    Bergman S, Graeme-Cook F, Pitman MB.
    Mod Pathol; 1997 Dec; 10(12):1258-64. PubMed ID: 9436973
    [Abstract] [Full Text] [Related]

  • 2. Can CD34 discriminate between benign and malignant hepatocytic lesions in fine-needle aspirates and thin core biopsies?
    de Boer WB, Segal A, Frost FA, Sterrett GF.
    Cancer; 2000 Oct 25; 90(5):273-8. PubMed ID: 11038423
    [Abstract] [Full Text] [Related]

  • 3. Reticulin stain in the fine needle aspiration differential diagnosis of liver nodules.
    Gagliano EF.
    Acta Cytol; 1995 Oct 25; 39(3):596-8. PubMed ID: 7539204
    [No Abstract] [Full Text] [Related]

  • 4. Cytologic features and histologic correlations of microacinar and microtrabecular types of well-differentiated hepatocellular carcinoma in fine-needle aspiration biopsy.
    Yang GC, Yang GY, Tao LC.
    Cancer; 2004 Feb 25; 102(1):27-33. PubMed ID: 14968415
    [Abstract] [Full Text] [Related]

  • 5. Reticulin loss in benign fatty liver: an important diagnostic pitfall when considering a diagnosis of hepatocellular carcinoma.
    Singhi AD, Jain D, Kakar S, Wu TT, Yeh MM, Torbenson M.
    Am J Surg Pathol; 2012 May 25; 36(5):710-5. PubMed ID: 22498821
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver.
    Lin F, Abdallah H, Meschter S.
    Diagn Cytopathol; 2004 Feb 25; 30(2):92-7. PubMed ID: 14755758
    [Abstract] [Full Text] [Related]

  • 7. Fine needle aspiration cytodiagnosis of liver tumors.
    Kuo FY, Chen WJ, Lu SN, Wang JH, Eng HL.
    Acta Cytol; 2004 Feb 25; 48(2):142-8. PubMed ID: 15085744
    [Abstract] [Full Text] [Related]

  • 8. Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies.
    Nassar A, Cohen C, Siddiqui MT.
    Diagn Cytopathol; 2009 Sep 25; 37(9):629-35. PubMed ID: 19405109
    [Abstract] [Full Text] [Related]

  • 9. Glypican-3 immunocytochemistry in liver fine-needle aspirates : a novel stain to assist in the differentiation of benign and malignant liver lesions.
    Kandil D, Leiman G, Allegretta M, Trotman W, Pantanowitz L, Goulart R, Evans M.
    Cancer; 2007 Oct 25; 111(5):316-22. PubMed ID: 17763368
    [Abstract] [Full Text] [Related]

  • 10. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.
    Coston WM, Loera S, Lau SK, Ishizawa S, Jiang Z, Wu CL, Yen Y, Weiss LM, Chu PG.
    Am J Surg Pathol; 2008 Mar 25; 32(3):433-44. PubMed ID: 18300806
    [Abstract] [Full Text] [Related]

  • 11. Value and limitations of cytologic criteria for the diagnosis of hepatocellular carcinoma by fine needle aspiration biopsy.
    Solé M, Calvet X, Cuberes T, Maderuelo F, Bruix J, Bru C, Rey MJ, Serna N, Cardesa A.
    Acta Cytol; 1993 Mar 25; 37(3):309-16. PubMed ID: 8388606
    [Abstract] [Full Text] [Related]

  • 12. A triple stain of reticulin, glypican-3, and glutamine synthetase: a useful aid in the diagnosis of liver lesions.
    Swanson BJ, Yearsley MM, Marsh W, Frankel WL.
    Arch Pathol Lab Med; 2015 Apr 25; 139(4):537-42. PubMed ID: 25822763
    [Abstract] [Full Text] [Related]

  • 13. The vascular architecture of renal cell carcinoma in fine-needle aspiration biopsies. An aid in its distinction from hepatocellular carcinoma.
    Weir M, Pitman MB.
    Cancer; 1997 Feb 25; 81(1):45-50. PubMed ID: 9100541
    [Abstract] [Full Text] [Related]

  • 14. Cytopathologic grading of hepatocellular carcinoma on fine-needle aspiration.
    Kulesza P, Torbenson M, Sheth S, Erozan YS, Ali SZ.
    Cancer; 2004 Aug 25; 102(4):247-58. PubMed ID: 15368317
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology.
    Saad RS, Luckasevic TM, Noga CM, Johnson DR, Silverman JF, Liu YL.
    Diagn Cytopathol; 2004 Jan 25; 30(1):1-6. PubMed ID: 14696137
    [Abstract] [Full Text] [Related]

  • 16. Unusual reticulin staining pattern in well-differentiated hepatocellular carcinoma.
    Hong H, Patonay B, Finley J.
    Diagn Pathol; 2011 Feb 22; 6():15. PubMed ID: 21338527
    [Abstract] [Full Text] [Related]

  • 17. Highly well differentiated hepatocellular carcinoma and benign hepatocellular lesions. Can they be distinguished on fine needle aspiration biopsy?
    Wee A, Nilsson B.
    Acta Cytol; 2003 Feb 22; 47(1):16-26. PubMed ID: 12585026
    [Abstract] [Full Text] [Related]

  • 18. Distinguishing well-differentiated hepatocellular carcinoma from benign liver by the physical features of fine-needle aspirates.
    Yang GC, Yang GY, Tao LC.
    Mod Pathol; 2004 Jul 22; 17(7):798-802. PubMed ID: 15044922
    [Abstract] [Full Text] [Related]

  • 19. Role of CD10 immunochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver.
    Ahuja A, Gupta N, Kalra N, Srinivasan R, Chawla Y, Rajwanshi A.
    Cytopathology; 2008 Aug 22; 19(4):229-35. PubMed ID: 18070122
    [Abstract] [Full Text] [Related]

  • 20. Biopsies of hepatocellular carcinoma with no reticulin loss: an important diagnostic pitfall.
    Yasir S, Chen ZE, Said S, Wu TT, Torbenson M.
    Hum Pathol; 2021 Jan 22; 107():20-28. PubMed ID: 33039370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.